This digital pill wants to make following your prescription easier
Most adults say they struggle with remembering to take their prescriptions. A nationwide study is testing a pill with an ingestible sensor that tracks medication adherence from inside the body.
As opioid crisis grows, babies and moms with hepatitis C fly under the radar
Among pregnant women, the hepatitis C infection rate nearly doubled in five years, fueled primarily by injection drug use linked to the opioid crisis, and the medical community is increasingly concerned that mothers and infants may go undetected and untreated…
Watch 5:19
News Wrap: Cyberattack cripples institutions, companies around the world
In our news wrap Friday, a massive cyberattack that infected computers with ransomware crippled major institutions and companies in scores of countries. Also, the Justice Department has issued a directive to federal prosecutors to seek tougher sentences for the vast…
Bid to speed transplants with hepatitis C-infected kidneys
WASHINGTON — Some patients facing a years-long wait for a kidney transplant are jumping ahead in line thanks to a startling experiment: They're agreeing to an organ almost sure to infect them with hepatitis C.
The Cherokee Nation, one of the largest Native American tribes, has become the first community in the U.S. to set a goal of eliminating hepatitis C from its population. Tribe officials plan to screen 300,000 members, whose prevalence of infection…
WASHINGTON — A bipartisan investigation by U.S. senators finds that the makers of a breakthrough drug for hepatitis C infection put profits before patients in pricing the $1,000-per-pill cure.
Medicare spending on breakthrough medications for hepatitis C will nearly double this year, passing $9 billion, according to new government figures.
Expensive specialty medicines used to treat cancer and chronic illnesses have forced some very ill Americans to choose between getting proper treatment and paying their rent. To ease the financial burden, the California agency that governs the state’s Affordable Care…
WASHINGTON — Your money or your life? Sovaldi, a new pill for hepatitis C, cures the liver-wasting disease in 9 of 10 patients, but treatment can cost more than $90,000. Leading medical societies recommend the drug as a first-line treatment,…
Additional Support Provided By:
